T900607
Term · Oncology and biomedicine · MLC-T-ONC-008479
A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called tubulin-binding agents.
A pentafluorophenylsulfonamide compound with potential antineoplastic activity. T900607 inhibits tubulin polymerization by binding irreversibly to colchicine binding sites, resulting in cell cycle arrest and apoptosis.
| Identifier | MLC-T-ONC-008479 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | T607; T900607 sodium |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-008479",
"term": "T900607",
"field": "Oncology and biomedicine",
"definitions": [
"A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called tubulin-binding agents.",
"A pentafluorophenylsulfonamide compound with potential antineoplastic activity. T900607 inhibits tubulin polymerization by binding irreversibly to colchicine binding sites, resulting in cell cycle arrest and apoptosis."
],
"synonyms": [
"T607",
"T900607 sodium"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/t900607/"
}
Record 15,924 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.